Tumor-on-a-chip method reveals timing as a factor in glioblastoma immunotherapy

Medical Xpress

A joint research team led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact with cancer cells can critically influence the therapeutic response in glioblastoma. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

Tumor-on-a-chip method reveals timing as a factor in glioblastoma immunotherapy

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Ad ASTRA Community Workshop Detailed Schedule & Abstracts

Newly discovered microprotein linked to type 2 diabetes, shows promise as a precision treatment

Image: Starburst galaxy Centaurus A

Medical Xpress의 다른 기사

Immune navigation system discovery could lead to better treatments for chronic inflammation

ICU design guidelines highlight how hospital environments shape patient care and safety

Preeclampsia rates in minority communities shed light on the social roots of maternal health disparities